The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No.
作者信息
Prasad V, Addeo A
机构信息
Department of Epidemiology and Biostatistics, University of California San Francisco, USA; Department of Medicine, University of California San Francisco, USA.
Department of Oncology, University Hospital of Geneva, Switzerland.
出版信息
Ann Oncol. 2020 Sep;31(9):1112-1114. doi: 10.1016/j.annonc.2020.07.001. Epub 2020 Aug 5.
PMID:32771305
Abstract
摘要
Zotero 插件